Publications

5539 Results

Selenium accumulates in prostate tissue of prostate cancer patients after short-term administration of selenomethlonine.

Authors
AL Sabichi;JJ Lee;RJ Taylor;IM Thompson Jr;BJ Miles;JW Basler;LL Platera;M Wargo;D Menter;CM Tangen;ED Crawford;SM Lippman
Journal / Conference
Proc of the American Association for Cancer Research 43:1007(#4993)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
S9812

Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial

Authors
JS Cooper;TF Pajak;AA Forastiere;J Jacobs;SB Saxman;JA Kish;HE Kim;AJ Cmelak;M Rotman;M Machtay;JF Ensley;KSC Chao;CJ Schultz;N Lee;KK Fu
Journal / Conference
Proc of the American Society of Clinical Oncology 21:226a(#903)
Year
2002
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9515 (RTOG-9501)

SWOG 9458: evaluation of Ki-67, p53 and angiogenesis in patients registered to SWOG 8710

Authors
HB Grossman;C Cordon-Cardo;R Cote;FM Waldman;C Tangen;ED Crawford
Journal / Conference
International Journal of Cancer Suppl.13:114 (#O140)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9458

Randomized phase III intergroup trial (CALGB 9732) of etoposide (VP-16) and cisplatin (DDP) with or without paclitaxel (TAX) and G-CSF in patients with extensive stage small cell lung cancer (ED-SCLC).

Authors
HB Niell;JE Herndon;AA Miller;DM Watson;A Sandler;K Kelly;R Marks;MR Green
Journal / Conference
Proc of the American Society of Clinical Oncology 21:293a(#1169)
Year
2002
Research Committee(s)
Lung
Study Number(s)
C9732

B-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer

Authors
WM Clements;J Wang;A Sarnaik;OJ Kim;JS Macdonald;C Fenoglio-Preiser;J Groden;AM Lowy
Journal / Conference
Cancer Research 62:3503-3506
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

N9741: oxaliplatin (oxal) or CPT-11 + 5-fluorouracil (5FU)/leucovorin (LV) or oxal + CPT-11 in advanced colorectal cancer (CRC). Initial toxicity and response data from a GI Intergroup study.

Authors
RM Goldberg;RF Morton;DJ Sargent;CS Fuchs;RK Ramanathan;SK Williamson;BP Findlay
Journal / Conference
Proc of the American Society of Clinical Oncology 21:128a(#511)
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
N9741

Impact of previous local treatment for prostate cancer on subsequent metastatic disease

Authors
IM Thompson;C Tangen;J Basler;ED Crawford
Journal / Conference
Journal of Urology 168:1008-1012
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089

Authors
RJ Green;JP Metlay;K Propert;PJ Catalano;JS Macdonald;RJ Mayer;DG Haller
Journal / Conference
Annals of Internal Medicine 136(4):261-269
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)

Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization

Authors
ML Slovak;F Zhang;L Tcheurekdjian;D Bobadilla;V Bedell;DA Arber;DL Persons;JA Sosman;JL Murata-Collins
Journal / Conference
Cancer Detection and Prevention 26:171-179
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9431

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

Authors
A Rosenwald;G Wright;WC Chan;JM Connors;E Campo;RI Fisher;RD Gascoyne;HK Muller-Hermelink;EB Smeland;LM Staudt;TM Grogan;TP Miller;M LeBlanc
Journal / Conference
New England Journal of Medicine 346(25):1937-1947
Year
2002
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819